DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride) by Ascentage Pharma is 12. Approved for attention deficit hyperactivity disorder (adhd) [see clinical studies (14)], attention deficit hyperactivity disorder (adhd) (1). First approved in 2021.
Drug data last refreshed 20h ago
12.1 Mechanism of Action Dexmethylphenidate hydrochloride is a CNS stimulant. The mode of therapeutic action in ADHD is not known. 12.2 Pharmacodynamics Dexmethylphenidate is the more pharmacologically active d -enantiomer of racemic methylphenidate. Methylphenidate blocks the reuptake of…
Worked on DEXMETHYLPHENIDATE HYDROCHLORIDE at Ascentage Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions
Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions